Surrey Heartlands

Joint Formulary & PAD

Beclometasone with formoterol (Bibecfo100/6) - Chronic Obstructive Pulmonary Disease (COPD)

You are here : Home > Formulary Search > Beclometasone with formoterol (Bibecfo100/6) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (Metered Dose)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
COPD Primary Care Medicines Management Guidelines - updated Jun 23
Webpage
How to use a metered dose inhaler (MDI) with a large volume spacer - video
Patient resource
How to use a metered dose inhaler (MDI) with a large volume spacer - Patient information leaflet
Patient resource
How to use a metered dose inhaler (MDI) - video

PAD Profile

ChemicalSubstance :
Beclometasone with formoterol (Bibecfo100/6)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
ICS LABA
Keywords :
ICS/LABAs, ICS LABAs, Respiratory, inhaled corticosteroids
Brand Names Include :
Bibecfo
Important Information :

Bibecfo 100/6 should be prescribed in preference to Fostair (equivalent) as it is a more cost-effective ICS/formoterol pMDI. Licensed for MART in adults.

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Chronic Obstructive Pulmonary Disease (COPD)
Supporting Documents :
4

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Beclometasone with formoterol (Bibecfo100/6) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).